About Maple Hospital
Maple Hospital is a publicly listed company based in Bharuch (India) founded in 2023. Cardiac care and medical services are provided through hospital networks. Its Indian entity Broach Lifecare Hospital Limited reported revenue of ₹6.03 Cr. Its focus areas include Hospital Chains, Single Specialty Hospital Chains, Cardiology and Clinic Chains. Its competitors include Madhavbaug, Heal Your Heart and Kant Multispeciality Hospital.
Company details
Maple Hospital was established in 2023 in Bharuch, India, within the healthcare sector. Operations are conducted via a network of hospitals and clinics, where cardiac care, surgical procedures, and mental health treatments are delivered. Additional medical services are extended to patients in the region, supporting comprehensive care needs in a localized setting.
- Headquarters Bharuch, India
- Stage Public
- SectorsHealthcare
- Website maplehospital.in
- Legal Name Broach Lifecare Hospital Limited
- Market Cap₹7.71 Cr
BROACH · BSE
- Share Price₹12.70
0.00% today
- Revenue₹5.99 Cr
FY 2025-26 · +88.4% YoY
- EBITDA₹0.50 Cr
Margin 8.3%
- Net Profit₹0.08 Cr
FY 2025-26 · -85.2% YoY
- P/E (TTM)88.8x
P/B 0.8x
Associated legal entities of Maple Hospital
Maple Hospital operates through Broach Lifecare Hospital Limited, a listed company (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Broach Lifecare Hospital Limited Listed CIN L86100GJ2023PLC140499 | Active | 25 Apr 2023 | Bharuch, Gujarat | ₹6.0 Cr | 5 | View details |
Board of directors of Broach Lifecare Hospital Limited (Maple Hospital)
Broach Lifecare Hospital Limited is the primary company behind Maple Hospital. The board of Broach Lifecare Hospital Limited currently have 5 directors; the longest-serving is Shachi Jaykumar Vyas, appointed in 2023. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Shachi Jaykumar Vyas DIN 09063799 | Whole-time director | 25 Apr 2023 | 3 yrs 6 mo | Broach Lifecare Hospital Limited |
| Jaykumar Narendra Vyas DIN 08736387 | Managing Director | 25 Apr 2023 | 3 yrs 6 mo | Broach Lifecare Hospital Limited |
| Dhyuti Krupesh Joshi DIN 08736388 | Director | 05 Oct 2023 | 3 yrs 1 mo | Broach Lifecare Hospital Limited |
| Mehul Narendrakumar Hingu DIN 10404685 | Director | 09 Dec 2023 | 2 yrs 11 mo | Broach Lifecare Hospital Limited |
| Shrikrishna Ramesh Chaudhari DIN 10427970 | Director | 15 Dec 2023 | 2 yrs 10 mo | Broach Lifecare Hospital Limited |
IPO & Listings of Maple Hospital
Maple Hospital is a publicly listed company on the BSE with ticker symbol BROACH in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date21 Aug 2024
- Listed onBSE: 544231
- Listed entityBroach Lifecare Hospital Limited
- Exchange sectorHealth services
- ISININE0SFZ01018
- Share price₹14.00 (-6.67% on the day) · 2026-10-05
- Volume (last session)6,000
Financials of Maple Hospital
Exchange-reported figures of Broach Lifecare Hospital Limited, the listed company behind Maple Hospital (BSE: BROACH).
Financial Highlights
FY 2025-26 · StandaloneRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 5.99 | 3.18 | 2.61 | 1.82 | 3.39 |
| Revenue growth | +88.4% | +21.8% | +43.4% | -46.3% | - |
| EBITDA | 0.50 | 0.83 | 1.03 | 0.75 | 0.96 |
| EBITDA margin | +8.4% | +26.1% | +39.5% | +41.2% | +28.3% |
| Profit before tax | 0.20 | 0.72 | 0.94 | 0.18 | 0.62 |
| Net profit | 0.08 | 0.54 | 0.70 | 0.14 | 0.70 |
| Net profit margin | +1.3% | +17.0% | +26.8% | +7.7% | +20.7% |
| EPS (₹) | 0.14 | 0.88 | 1.56 | 138.50 | 459.10 |
| Balance sheet | |||||
| Total assets | 9.45 | 10.41 | 5.47 | 8.10 | 4.81 |
| Net worth | 9.45 | 9.36 | 5.47 | 2.16 | 2.25 |
| Total debt | 0.00 | 1.05 | 0.00 | 5.94 | 2.55 |
| Cash & bank | 0.27 | 0.20 | 0.07 | 0.20 | 0.07 |
| Net working capital | 2.38 | 2.59 | 1.10 | 0.53 | (0.58) |
| Cash flow | |||||
| Cash from operations | 1.30 | (0.62) | (3.31) | (0.95) | 1.11 |
| Cash from investing | (0.14) | (3.64) | (1.39) | (1.78) | (2.79) |
| Cash from financing | (1.09) | 4.38 | 4.77 | 2.86 | 1.63 |
Financial Statements
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Revenue | 5.99 | 3.18 | 2.61 | 1.82 | 3.39 |
| Revenue growth | +88.4% | +21.8% | +43.4% | -46.3% | - |
| Other income | 0.04 | 0.05 | 0.00 | 0.11 | 0.08 |
| Total expenses | 5.49 | 2.35 | 1.58 | 1.07 | 2.43 |
| Employee cost | 0.00 | 0.64 | 0.48 | 0.38 | 0.47 |
| EBITDA | 0.50 | 0.83 | 1.03 | 0.75 | 0.96 |
| EBITDA margin | +8.4% | +26.1% | +39.5% | +41.2% | +28.3% |
| Depreciation | 0.30 | 0.13 | 0.09 | 0.41 | 0.33 |
| Interest | 0.04 | 0.03 | 0.00 | 0.27 | 0.09 |
| Profit before tax | 0.20 | 0.72 | 0.94 | 0.18 | 0.62 |
| Tax | 0.12 | 0.18 | 0.24 | 0.05 | 0.16 |
| Net profit | 0.08 | 0.54 | 0.70 | 0.14 | 0.70 |
| Net profit margin | +1.3% | +17.0% | +26.8% | +7.7% | +20.7% |
| EPS (₹) | 0.14 | 0.88 | 1.56 | 138.50 | 459.10 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | 6.07 | 6.07 | 4.46 | 0.01 | 0.01 |
| Reserves & surplus | 3.38 | 3.29 | 1.01 | 2.15 | 2.24 |
| Shareholders' funds (net worth) | 9.45 | 9.36 | 5.47 | 2.16 | 2.25 |
| Secured loans | 0.00 | 1.05 | 0.00 | 4.53 | 1.76 |
| Unsecured loans | 0.00 | 0.00 | 0.00 | 1.41 | 0.79 |
| Total debt | 0.00 | 1.05 | 0.00 | 5.94 | 2.55 |
| Total liabilities | 9.45 | 10.41 | 5.47 | 8.10 | 4.81 |
| Assets | |||||
| Gross block | 4.55 | 1.57 | 1.39 | 7.28 | 5.40 |
| Net block | 4.55 | 1.57 | 1.30 | 6.38 | 4.91 |
| Capital work in progress | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.14 | 3.24 | 0.00 | 0.00 | 0.00 |
| Inventories | 0.40 | 0.42 | 0.28 | 0.00 | 0.00 |
| Sundry debtors | 0.91 | 0.60 | 0.31 | 0.12 | 0.02 |
| Cash & bank balances | 0.27 | 0.20 | 0.07 | 0.20 | 0.07 |
| Loans & advances | 1.94 | 1.82 | 0.66 | 0.30 | 0.44 |
| Total current assets | 3.52 | 3.04 | 1.32 | 0.62 | 0.53 |
| Total current liabilities | 1.14 | 0.45 | 0.22 | 0.09 | 1.11 |
| Net working capital | 2.38 | 2.59 | 1.10 | 0.53 | (0.58) |
| Total assets | 9.45 | 10.41 | 5.47 | 8.10 | 4.81 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Opening cash | 0.20 | 0.07 | 0.00 | 0.07 | 0.12 |
| Net cash from operating activities | 1.30 | (0.62) | (3.31) | (0.95) | 1.11 |
| Net cash from investing activities | (0.14) | (3.64) | (1.39) | (1.78) | (2.79) |
| Net cash from financing activities | (1.09) | 4.38 | 4.77 | 2.86 | 1.63 |
| Net change in cash | 0.08 | 0.12 | 0.07 | 0.13 | (0.05) |
| Closing cash | 0.27 | 0.20 | 0.07 | 0.20 | 0.07 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +88.4% | +21.8% | +43.4% | -46.3% | - |
| EBITDA growth | -39.8% | -19.4% | +37.3% | -21.9% | - |
| PBT growth | -72.2% | -23.4% | +422.2% | -71.0% | +9997.0% |
| Net income growth | -85.2% | -22.9% | +400.0% | -80.0% | - |
| Revenue CAGR (3Y) | +48.8% | -2.1% | - | - | - |
| EBITDA CAGR (3Y) | -12.6% | -4.7% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +1.3% | +17.0% | +26.8% | +7.1% | +13.6% |
| Return on capital employed | - | +9.5% | +13.9% | +7.1% | +21.5% |
| Return on net worth | - | +7.3% | +18.4% | +6.4% | +31.1% |
| Debt / equity | - | 0.07 | 0.78 | 1.93 | 1.13 |
| Long-term debt / equity | - | 0.00 | 0.75 | 1.86 | 1.11 |
| Interest cover | 20.00 | 4.29 | 0.00 | 79.41 | 14.29 |
| Efficiency & per share | |||||
| Fixed asset turnover | - | 2.15 | 0.60 | 0.29 | 0.63 |
| Inventory turnover | - | 9.09 | 18.64 | 0.00 | 0.00 |
| Debtors turnover | - | 6.99 | 12.14 | 26.00 | 169.50 |
| EPS (₹) | 0.14 | 0.88 | 1.56 | 138.50 | 459.10 |
| Dividend per share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (₹) | 0.00 | 15.43 | 12.26 | 2,163.20 | 2,251.40 |
Competitors of Maple Hospital
Maple Hospital has 3 listed competitors in our database. They include Madhavbaug, Heal Your Heart and Kant Multispeciality Hospital.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| madhavbaug.org | 2014 | Thane, India | 295 | A chain of cardiac care hospitals and clinics is operated. | ||
| healurheart.com | 2016 | Chennai, India | 18 | Operates a chain of centers for EECP therapy and cardiac rehabilitation. | ||
| kantmultispecialityhospital.com | 2022 | Faridabad, India | A multispeciality hospital offering advanced medical and surgical treatments with the latest technology. |
Detailed competitors of Maple Hospital
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Hospitals & Clinical Care
3 companies that operate in the same segment as Maple Hospital (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Maternity, childcare, and fertility services are delivered via hospital chains. | 2007 | Bengaluru, Karnataka, India | USD 204.87 M | USD 140.46 M | 4,459 | |
Chain of oncology hospitals | 1989 | Bengaluru, Karnataka, India | USD 36.59 M | USD 270.51 M | 321 | |
Chain of multi-super specialty healthcare hospitals | 2004 | Gurugram, Haryana, India | USD 104.7 M | USD 461.72 M | 12,240 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Maple Hospital
Complete news archive for Maple Hospital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maple Hospital
Maple Hospital was founded in 2023.
Maple Hospital is headquartered in Bharuch, India. It is registered at Bharuch, Gujarat, India.
The primary company behind Maple Hospital, Broach Lifecare Hospital Limited, reported revenue of ₹6.03 Cr for FY 2026, up 88% year on year.
Maple Hospital was established in 2023 in Bharuch, India, within the healthcare sector. Operations are conducted via a network of hospitals and clinics, where cardiac care, surgical procedures, and mental health treatments are delivered. Additional medical services are extended to patients in the region, supporting comprehensive care needs in a localized setting.
Maple Hospital's top competitors include Madhavbaug, Heal Your Heart and Kant Multispeciality Hospital.
Yes, Maple Hospital is publicly traded on BSE under the ticker symbol BROACH.
Maple Hospital operates through Broach Lifecare Hospital Limited.
The legal entities of Maple Hospital currently have 5 directors, including Shachi Jaykumar Vyas, Jaykumar Narendra Vyas, Mehul Narendrakumar Hingu and others.